Optimal Handling of Common Bile Duct Calculus, a Prospective Study
NCT ID: NCT01708109
Last Updated: 2019-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
35 participants
INTERVENTIONAL
2011-11-27
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Common Bile Duct Stones - Natural History and Interventions
NCT01734720
Laparoscopic Endobiliary Stent and Postoperative ERCP Compared to Intraoperative ERCP
NCT06817291
Efficacy of Choleretics in Acalculous Gallbladder in Situ After Endoscopic Removal of Biliary Stones
NCT01829139
Laparoscopic Treatment of Common Bile Duct Stones : What Are the Limits and When Should we Call the Endoscopist ?
NCT04467710
ChOlanGiography Performed Routinely Versus Selectively During Cholecystectomy: A NAtional Registry-based Randomized Controlled Trial
NCT07002619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biliary calculus remain
biliary calculus, less than or equal to 6 mm, remains
no measures taken to clear bile ductus
biliary calculus remain
Biliary calculus removed
biliary calculus, less than or equal to 6 mm, removed
clearance of bile ductus
biliary calculus removed at surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no measures taken to clear bile ductus
biliary calculus remain
clearance of bile ductus
biliary calculus removed at surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of anamneses pancreatitis/icterus
* Allergy against x-ray contrast
* Stones more than 6 mm in ductus
* No passage of contrast to duodenum
* malignant
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska University Hospital
OTHER
Danderyd Hospital
OTHER
Sodertalje Hospital
OTHER
Mora Hospital
UNKNOWN
Regional Hopspital Ryhov, Jönköping
UNKNOWN
University Hospital, Linkoeping
OTHER
Vrinnevi Hospital, Norrköping
UNKNOWN
Sundsvalls Hospital
UNKNOWN
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anders Thorell
Ass. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anders Thorell, Assoc Prof
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Regional Hospital Ryhov
Jönköping, , Sweden
Linköping University Hospital
Linköping, , Sweden
Mora Hospital
Mora, , Sweden
Vrinnevi Hospital Norrköping
Norrköping, , Sweden
Södertälje Hospital
Södertälje, , Sweden
Ersta sjukhus
Stockholm, , Sweden
Karolinska University Hospital
Stockholm, , Sweden
Danderyds Hospital
Stockholm, , Sweden
Sundsvalls Hospital
Sundsvall, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011/873-31/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.